Cargando…
Long-term efficacy of HDM-SCIT in pediatric and adult patients with allergic rhinitis
BACKGROUND: Subcutaneous immunotherapy (SCIT) is a well-validated and effective disease modification treatment for house dust mites (HDM)-induced allergic rhinitis (AR). Long-term post-treatment comparisons in children and adults treated with SCIT have rarely been published. This study aimed to eval...
Autores principales: | Ren, Lei, Wang, Chengshuo, Xi, Lin, Gao, Yunbo, Zhang, Yuan, Zhang, Luo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007655/ https://www.ncbi.nlm.nih.gov/pubmed/36906588 http://dx.doi.org/10.1186/s13223-023-00781-8 |
Ejemplares similares
-
Comparison of Long-term Efficacy of Subcutaneous Immunotherapy in Pediatric and Adult Patients With Allergic Rhinitis
por: Huang, Yanran, et al.
Publicado: (2018) -
Comparative study of novel dosing schedules for interrupted immunotherapy for allergic rhinitis
por: Xi, Lin, et al.
Publicado: (2022) -
Omalizumab is effective in the preseasonal treatment of seasonal allergic rhinitis
por: Zhang, Yuan, et al.
Publicado: (2022) -
Long-term benefit after allergen immunotherapy to HDM in elderly patients with allergic rhinitis
por: Bożek, Andrzej, et al.
Publicado: (2023) -
Clinical response to subcutaneous immunotherapy at 3 years in allergic rhinitis patients is predicted by short‐term treatment effectiveness
por: Liu, Dong, et al.
Publicado: (2023)